KEQU Stock Forecast: Kewaunee Scientific Corp. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 49 of 100 as at 21 Nov 2026 — in the lower half.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Kewaunee Scientific Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (91): The share count has been shrinking and the company is not leaning on new borrowing.
Momentum (17): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
KEQU stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on KEQU, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
KEQU appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
KEQU vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, Kewaunee Scientific Corp. returned −10.6% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
KEQU analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 12.5×
- Price / sales
- 0.4×
- Price / book
- 1.3×
- EV / EBITDA
- 7.0×
Cheaper than 63% of US stocks
Cheaper than 84% of US stocks
Cheaper than 59% of US stocks
Cheaper than 73% of US stocks
- Revenue growth (YoY)
- −6.7%
- Earnings growth (YoY)
- −44.8%
- Gross margin
- 29.8%
- Operating margin
- 5.4%
- Net margin
- 3.0%
Higher than 19% of US stocks
Higher than 12% of US stocks
Higher than 34% of US stocks
Higher than 54% of US stocks
Higher than 51% of US stocks
- Return on equity
- 12.5%
- Return on assets
- 5.1%
- Dividend yield
- 2.2%
Higher than 68% of US stocks
Higher than 76% of US stocks
Higher than 47% of US dividend payers
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Kewaunee Scientific Corp. has a market value of $99.9M and an enterprise value of $149.3M.
Revenue in the twelve months to 30 Apr 2026: $282.0M. The latest quarter shrank 7.5% year on year.
Net income over the same four quarters: $10.5M, a 3.7% net margin.
Diluted earnings per share, trailing twelve months: $3.22.
Free cash flow in the twelve months to 30 Apr 2026: $14.7M, after $3.9M of capital spending.
Trailing P/E: 12.5×; forward P/E: 16.0× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 2.25%.
Kewaunee Scientific Corp. employs 1,231 people — $229K of revenue per employee.
Data provided by Twelve Data
KEQU and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at KEQU’s peer groups, ranked by the model: consumer staples stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Kewaunee Scientific Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about KEQU
How does Ticker Nerd's model rank KEQU?
As at 21 Nov 2026, Kewaunee Scientific Corp. ranks 49 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Issuance (91 of 100).
What is the KEQU stock forecast for 2030?
No analyst covering Kewaunee Scientific Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for KEQU are extrapolating price history, which says nothing about the business.
How has KEQU stock performed over the past year?
Kewaunee Scientific Corp. returned -10.6% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Kewaunee Scientific Corp. do?
Kewaunee Scientific Corporation Common Stock represents Kewaunee Scientific Corporation, a specialized manufacturer and installer of laboratory, healthcare, and technical furniture and related infrastructure products. Kewaunee Scientific Corporation serves customers that require durable, purpose-built environments for scientific research, clinical settings, education, and other technical applications.
About Kewaunee Scientific Corp.
Kewaunee Scientific Corporation Common Stock represents Kewaunee Scientific Corporation, a specialized manufacturer and installer of laboratory, healthcare, and technical furniture and related infrastructure products. Kewaunee Scientific Corporation serves customers that require durable, purpose-built environments for scientific research, clinical settings, education, and other technical applications. Its product portfolio includes laboratory casework, fume hoods, containment solutions, and custom furnishings designed to support safe, organized, and efficient workspaces. The company operates across domestic and international markets through its current business segments, providing integrated solutions that combine design, manufacturing, and installation services. With a focus on highly regulated and performance-driven environments, Kewaunee Scientific Corporation plays a niche role in the broader healthcare equipment and scientific infrastructure market.
CEO Mr. Thomas David Hull III · 1,231 employees · United States · https://kewaunee.com